04:42:23 EDT Sat 15 Aug 2020
Enter Symbol
or Name

Sirona Biochem Corp
Symbol SBM
Shares Issued 226,309,320
Close 2020-06-15 C$ 0.275
Recent Sedar Documents

Sirona Biochem ships first batch of TFC-1067 to Rodan

2020-06-16 06:33 ET - News Release

Dr. Howard Verrico reports


Sirona Biochem Corp. has made its first shipment of compound TFC-1067 to industry leader Rodan + Fields LLC's formulation team. Rodan + Fields will be the first to market for a consumer product utilizing TFC-1067 for the treatment of dyschromia (hyperpigmentation or dark spots of the skin).

Using the services and expertise of contract research organization Roowin SA Sirona scaled up production to the multikilogram level. The synthetic process was refined to yield a large supply of high-purity TFC-1067 to meet the exacting standards for a high-quality product. Roowin will be providing a further supply of TFC-1067 near term as production continues. Sirona management is currently in advanced negotiations with Chinese producers regarding large-scale manufacturing of TFC-1067 and expects to sign an agreement in this regard within the next quarter. Part of the strategic plan is to build up an inventory of commercially ready TFC-1067 through two manufacturing sites. This will enable a quick response to anticipated demands from other companies using a diversified supply channel. Further details of the product launch will remain confidential for strategic reasons.

Sirona also announces a successful attendance at BIO Digital, June 8 to June 12, 2020. Interest in TFC-1067 and anti-aging from international cosmetic companies was high during the virtual conference. The advancement of TFC-1067 through clinical and manufacturing has established a significant level of interest as the compound is much more attractive to companies. Having a ready supply of inventory and established manufactures vastly decreases the risk for organizations looking to add TFC-1067 to their product lines.

About Sirona Biochem Corp.

Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology. Sirona Biochem's subsidiary lab, TFChem, specializes in stabilizing carbohydrate molecules with the goal of improving efficacy and safety. New compounds are patented for maximum revenue potential. Sirona Biochem's compounds are licensed to leading companies around the world in return for licensing fees, milestone fees and continuing royalty payments.

We seek Safe Harbor.

© 2020 Canjex Publishing Ltd. All rights reserved.